Using EMR to Improve Statin Adherence in MHS

by U.S. Medicine

January 12, 2018

DURHAM, NC — Even though HMG-CoA reductase inhibitors (statins) lower cholesterol and prevent cardiovascular disease, nearly half of patients stop taking statin medications one year after they are prescribed.

A study published by PLoS One noted that discontinuation of the medication leads to higher cholesterol levels, increased cardiovascular risk and costs due to excess hospitalizations. One way to individualize therapy and improve adherence, according to the research, is to identify patients at highest risk for not following their long-term statin regimen.1

A study team from Duke University and the Air Force Medical Operations Agency at Joint Base Lackland-Kelly, TX, focused on electronic health records (EHR) as an increasingly common source of data that are challenging to analyze but have potential for generating more accurate predictions of disease risk.

Their study sought to create an EHR based model for statin adherence and link it to biologic and clinical outcomes in patients receiving statin therapy. To do that, researchers gathered EHR data from the MHS, which maintains administrative data for active duty, retirees and dependents of the U.S. military who receive health care benefits.

With data collected from patients prescribed their first statin prescription in 2005 and 2006, baseline billing, laboratory, and pharmacy claims data were pulled together from the two years leading up to the first statin prescription. Follow-up statin prescription refill data was used to define the adherence outcome, defined as more than 80% days covered. The study team also looked at overall disease risk and statin adherence. Overall, the analytical dataset included about 139,000 patients.

Predicted statin adherence for each patient was subsequently used to correlate with cholesterol lowering and hospitalizations for cardiovascular disease during the five year follow-up.

Results indicated that the predicted statin adherence was independently associated with greater cholesterol lowering (correlation = 0.14, p < 1e-20) and lower hospitalization for myocardial infarction, coronary artery disease, and stroke (hazard ratio = 0.84, p = 1.87E-06).

“Electronic health records data can be used to build a predictive model of statin adherence that also correlates with statins’ cardiovascular benefits,” the study team concluded.

  1. Lucas JE, Bazemore TC, Alo C, Monahan PB, Voora D. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System. PLoS One. 2017 Nov 20;12(11):e0187809. doi: 10.1371/journal.pone.0187809. eCollection 2017. PubMed PMID: 29155848; PubMed Central PMCID: MC5695792.

Related Articles

VA Research Determines Which Beta Blocker Is Better in Heart Failure

ST. LOUIS—Current clinical guidelines recommend the use of beta blockers in all heart failure patients with with reduced ejection fraction (HFrEF). Which beta blocker to use—carvedilol or metoprolol succinate—remained unclear, however, according to a recent... View Article

New VA Analysis Refutes Link Between Heart Failure, Incident Cancer

With about 350,000 patients with heart failure diagnoses being treated in the VHA, recent studies suggesting that the cardiovascular condition increases risk of cancer have been worrisome.

U.S. Medicine Recommends

More From pharmacy clinical topics


VA Hospitals First to Publicly Report Opioid Prescribing Rates

In January, the VA became the first hospital system in the United States to publicly post opioid prescribing rates.


Long-term Opioid Prescribing Declines in VHA, Bucking National Trend

Extended Prescribing Dropped from 9.5% in 2012 to 6.2% in 2016 By Brenda L. Mooney IOWA CITY, IA—Long-term prescribing of opioid painkillers is on the decline at the VA, in contrast to what appears to be happening outside of federal medicine.


VA Study Addresses Concerns About Anti-Epileptic Drugs, Suicidal Behavior Link

In 2008, the U.S. Food and Drug Administration issued an alert about increased risk for suicidal ideation and behavior for patients taking anti-epileptic drugs (AEDs).


Surveys Show Why VA Good Prescribing Practice Also Should Include Deprescribing

STATESBORO, GA—What factors can cause delays in initiation of initial disease-modifying antirheumatic drug, or DMARD, in patients newly diagnosed with rheumatoid arthritis (RA)? A retrospective cohort descriptive study used administrative data from the TRICARE program... View Article


Post-Menopausal Veterans Frequently Prescribed Long-term Opioid Therapy

The VA has focused on reducing the risk of opioid abuse and addiction by issuing guidance that strongly recommends against the use of the painkillers for chronic pain since the implementation of the Opioid Safety Initiative in 2013.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up